Plasma half-life of phenylbutazone in patients with impaired liver function. (Q53696322): Preview

Plasma half-life of phenylbutazone in patients with impaired liver function. (Q53696322)
scientific article

Language:

Current Data About Plasma half-life of phenylbutazone in patients with impaired liver function.

(P31)

(Q13442814)

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

(P304)

171-177

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

(P407)

(Q1860)

(P433)

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

(P478)

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

(P577)

Friday, February 1, 1974

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

(P1433)

(Q1101529)

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

(P1476)

"Plasma half-life of phenylbutazone in patients with impaired liver function." (language: en)

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

(P2093)

Hvidberg EF

(P1545)	1

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

Andreasen PB

(P1545)	2

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

Ranek L

(P1545)	3

(P248)
(P698)	4855829
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4855829

other details

description	scientific article

External Links

(P356)	10.1002/CPT1974152171
(P698)	4855829